Insider Holders & Insider Ownership - Viracta Therapeutics Inc. (VIRX)

List of insiders holdings for Viracta Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
aMoon 2 Fund Limited Partnership
Schindel Yair Chaim
10% Owner		2023-01-10 17:21:237,392,237
0		7,392,237Form 13D
Growth Equity Opportunities Fund LLC
New Enterprise Associates 12 Limited Partnership
NEA 12 GP LLC
NEA Partners 12 Limited Partnership
NEWHALL CHARLES W III
KRAMLICH C RICHARD
BARRIS PETER J
PERRY MARK W
BARRETT M JAMES
SANDELL SCOTT D
10% Owner		2014-08-13 15:50:106,591,864
0		6,591,864Form 13D
BARRETT M JAMES
10% Owner		2014-08-29 17:38:160
4,659,333		4,659,333Form 4
SANDELL SCOTT D
10% Owner		2014-08-29 17:42:340
4,659,333		4,659,333Form 4
KOLLURI KRISHNA KITTU
10% Owner		2014-08-29 17:41:570
4,659,333		4,659,333Form 4
KERINS PATRICK J
10% Owner		2014-08-29 17:41:250
4,659,333		4,659,333Form 4
DRANT RYAN D
10% Owner		2014-08-29 17:40:410
4,659,333		4,659,333Form 4
BASKETT FOREST
10% Owner		2014-08-29 17:39:390
4,659,333		4,659,333Form 4
BARRIS PETER J
10% Owner		2014-08-29 17:39:040
4,659,333		4,659,333Form 4
TRAINOR III EUGENE A
10% Owner		2009-11-03 16:52:580
4,331,159		4,331,159Form 4
LINEHAN CHARLES M
10% Owner		2009-11-03 16:52:420
4,331,159		4,331,159Form 4
Semon Dominique
10% Owner		2010-05-04 18:36:330
3,921,095		3,921,095Form 4
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
UBS Oncology Impact Fund L.P.
10% Owner		2020-02-05 14:13:342,809,912
0		2,809,912Form 13G
BAY CITY CAPITAL LLC
Bay City Capital Management V LLC
Bay City Capital Fund V L.P.
Bay City Capital Fund V Co-Investment Fund L.P.
10% Owner		2017-11-07 16:02:351,828,968
0		1,828,968Form 13D
WARBURG PINCUS EQUITY PARTNERS LP
WARBURG PINCUS & CO
Warburg Pincus Partners LLC
WARBURG PINCUS LLC
10% Owner		2009-11-09 16:20:471,671,885
0		1,671,885Form 13D
MAYFIELD IX
MAYFIELD IX MANAGEMENT LLC
MAYFIELD ASSOCIATES FUND III L P
MAYFIELD VIII MANAGEMENT LLC
UNGER WILLIAM D
AUKEN WENDELL G VAN III
FONG KEVIN A
MYERS FRANK G JR
DALAL YOGEN K
HEIDRICH A GRANT III
10% Owner		2006-02-13 16:47:381,298,784
0		1,298,784Form 13G
CREDIT SUISSE
CREDIT SUISSE FIRST BOSTON EQUITY PARTNERS L.P.
CREDIT SUISSE FIRST BOSTON EQUITY PARTNERS (BERMUDA) L.P.
EMA PARTNERS FUND 2000 L.P.
EMA PRIVATE EQUITY FUND 2000 L.P.
CREDIT SUISSE FIRST BOSTON U.S. EXECUTIVE ADVISORS L.P.
CREDIT SUISSE FIRST BOSTON ADVISORY PARTNERS LLC
CREDIT SUISSE FIRST BOSTON (BERMUDA) LTD
HEMISPHERE PRIVATE EQUITY PARTNERS LTD.
HEMISPHERE PRIVATE EQUITY PARTNERS CHARITABLE TRUST
10% Owner		2010-02-16 15:09:551,206,590
0		1,206,590Form 13G
ROYSTON IVOR
Director		2024-09-12 18:13:15890,179
18,599		908,778Form 4
ALTA BIOPHARMA PARTNERS III LP
ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG
ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC
ALTA BIOPHARMA MANAGEMENT III LLC
PENHOET EDWARD
DELEAGE JEAN
CHAMPSI FARAH
Former 10% Owner		2015-02-12 16:12:09832,909
0		832,909Form 13G
ALTA BIOPHARMA PARTNERS III LP
MARDUEL ALIX
PENHOET EDWARD
ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG
ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC
ALTA BIOPHARMA MANAGEMENT III LLC
DELEAGE JEAN
CHAMPSI FARAH
10% Owner		2015-02-12 16:12:09832,909
0		832,909Form 13G
Faerm Michael E.
Chief Financial Officer		2024-05-16 16:26:48500,000
0		500,000Form 4
Quinn William P.
See Remarks		2020-04-02 15:30:39487,697
0		487,697Form 4
Rothera Mark
President and CEO		2024-03-13 20:36:16475,000
0		475,000Form 4
Fox Judith A.
See Remarks		2020-04-02 15:25:35457,500
0		457,500Form 4
DePinto Joseph I
EVP, CCO		2014-03-04 20:52:09300,000
0		300,000Form 4
Aisling Capital IV LP
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
SCHIFF ANDREW N
ELMS STEVE
10% Owner		2022-02-14 12:14:03288,571
0		288,571Form 13G
EVNIN ANTHONY B
Director		2009-04-07 15:07:270
266,532		266,532Form 4
Burcar Melody
Senior VP, Finance		2024-03-22 16:07:14260,750
0		260,750Form 3
Swisher Daniel N JR
President and CEO		2017-07-12 17:32:00257,759
0		257,759Form 4
Chevallard Daniel R.
CFO and COO		2024-03-13 20:29:45200,000
0		200,000Form 4
Rojkjaer Lisa
Chief Medical Officer		2023-03-17 17:03:25150,000
0		150,000Form 4
Pomerantz Roger
Director		2024-09-12 18:10:04144,547
0		144,547Form 4
Cohen Darrel P.
Chief Medical Officer		2024-03-13 20:33:00120,000
0		120,000Form 4
BJERKHOLT ERIC
EVP, CFO & Corp. Secretary		2016-12-06 19:57:3195,000
0		95,000Form 4/A
Gullotta Tina
VP, Finance		2020-06-05 15:18:2990,500
0		90,500Form 4
ADELMAN DANIEL C MD
Sr. VP, Development and CMO		2007-09-14 17:40:0790,000
0		90,000Form 4
Roshwalb Gur
Director
10% Owner		2021-03-30 20:18:2980,000
0		80,000Form 4
Pierce Valerie L
SVP & General Counsel		2008-07-02 20:23:0167,500
0		67,500Form 4/A
Ketchum Steven B
Director		2020-07-01 16:45:2560,000
0		60,000Form 4
Carchedi Steve
Director		2020-07-01 16:46:3560,000
0		60,000Form 4
YOUNG JAMES W
Director		2020-07-01 16:52:5260,000
0		60,000Form 4
Wolff Henry Ward
Director		2020-07-01 16:55:1160,000
0		60,000Form 4
Pearce Homer L
Director		2020-07-01 17:08:1760,000
0		60,000Form 4
Misfeldt Dayton
See Remarks		2020-07-01 17:15:0360,000
0		60,000Form 4
STUMP DAVID C
Director		2020-07-01 16:39:2260,000
0		60,000Form 4
McDowell Robert Scott
Vice President, Research		2007-09-14 18:57:5060,000
0		60,000Form 4
Hyare Parvinder S
See Remarks		2021-01-07 18:01:0155,550
0		55,550Form 3
Simon Barry J.
Director		2024-06-24 19:44:1850,000
0		50,000Form 4
Barlow Jane F
Director		2024-06-24 19:43:0650,000
0		50,000Form 4
Fust Matthew
Director		2016-07-05 18:25:1450,000
0		50,000Form 4
Rubino Stephen
Director		2024-06-24 19:39:1250,000
0		50,000Form 4
DARCY THOMAS E
Director		2024-06-24 19:46:1650,000
0		50,000Form 4
Murphy Samuel Lafayette
Director		2024-06-24 19:47:1650,000
0		50,000Form 4
Chung Jane
Director		2024-06-24 19:48:1350,000
0		50,000Form 4
Borellini Flavia
Director		2024-06-24 19:49:1450,000
0		50,000Form 4
Winter Daryl B
SVP of I.P./Corp. Secretary		2006-12-04 16:52:2445,000
0		45,000Form 4
ONETTO NICOLE
Director		2022-06-10 17:07:4840,000
0		40,000Form 4
Huang Michael
Director		2022-06-10 16:59:2140,000
0		40,000Form 4
Kim Helen Susan
Director		2015-07-01 21:09:4840,000
0		40,000Form 4
Parker Geoffrey M.
Director		2017-06-02 17:22:4025,000
0		25,000Form 4
Craig Adam R
EVP, Development & CMO		2015-03-02 19:49:3123,452
0		23,452Form 4
HURWITZ EDWARD
Director		2013-07-02 18:56:4720,000
0		20,000Form 4
FODOR STEPHEN P A
Director		2008-06-05 17:10:1510,000
0		10,000Form 4
GOLDBY STEVEN D
Director		2008-06-06 14:31:1610,000
0		10,000Form 4
Wells James A
Director		2008-06-05 17:19:3910,000
0		10,000Form 4
LEFF JONATHAN S
Director
10% Owner		2008-06-05 16:52:0710,000
0		10,000Form 4
Growth Equity Opportunities Fund LLC
New Enterprise Associates 12 Limited Partnership
NEA Partners 12 Limited Partnership
NEA 12 GP LLC
10% Owner		2021-03-10 21:40:220
0		0Form 13D
BIOGEN IDEC INC
BIOGEN IDEC MA INC
10% Owner		2012-02-13 16:08:040
0		0Form 13G
HIRSCH RUSSELL C
Director		2005-09-27 07:56:050
0		0Form 3